Skip to main content

Table 3 Multivariate logistic regression analysis of the risk factors for the occurrence of LO-NEC in VPIs

From: The role of nutrition in analysis of risk factors and short-term outcomes for late-onset necrotizing enterocolitis among very preterm infants: a nationwide, multicenter study in China

Variables

LO-NEC onset

aβ/OR a (95% CI)

8 ~ 14d vs. 0d

aβ/OR a (95% CI)

> 14d vs. 0d

aβ/OR a (95% CI)

8 ~ 14d vs. > 14d

 

LO-NEC occurring between 8 ~ 14d

LO-NEC occurring after 14d

non-LO-NEC

 

(n = 128)

(n = 84)

(n = 2297)

   

Early feeding

65 (50.8)

47 (56.0)

1217 (53.0)

0.42 (0.14 ~ 0.84)

0.94 (0.47 ~ 2.89)

0.28 (0.19 ~ 0.77)

High proportion of breastfeeding

27 (21.1)

33 (39.3)

1072 (46.7)

0.25 (0.10 ~ 0.78)

0.53 (0.08 ~ 0.89)

0.37 (0.15 ~ 0.82)

Fasting time

7.8 (4.0,10.0)

6.7 (4.5,8.0)

1.5 (0.7,4.0)

-4.65 (− 6.02 ~ − 2.14)

-3.32 (− 5.18 ~ − 2.07)

-1.12 (− 7.88 ~ 2.55)

Cumulative dose of MCT/LCT emulsion during W1

13.8 (10.2,15.9)

12.6 (9.5,13.8)

12.2 (9.7,14.7)

-3.44 (− 7.19 ~ − 1.16)

-2.07 (− 8.43 ~ 1.97)

-3.59 (− 6.45 ~ − 2.76)

Gestational age

29.8 (28.5,30.7)

30.0 (28.8,30.9)

30.1 (28.9,31.1)

-1.98 (− 5.64 ~ − 0.45)

-1.34 (− 6.78 ~ 4.96)

-1.47 (− 5.19 ~ 3.84)

Grade III-IV NRDS

24 (18.8)

14 (16.7)

336 (14.6)

3.32 (1.76 ~ 6.45)

2.11 (0.75 ~ 5.87)

2.43 (0.68 ~ 7.54)

  1. MCT/LCT Medium-chain and long-chain triglyceride, NRDS Neonatal respiratory distress syndrome, HMF Human milk fortifier, W1 the first week after birth, BW Birth weight, IMV Invasive mechanical ventilation, hsPDA Hemodynamically significant patent ductus arteriosus, EOS Early-onset sepsis
  2. aAdjusted for the amount of HMF, days for full fortification, cumulative calories during W1, days to regain BW, IMV, Apgar score ≤ 7 at 5 min, antenatal steroids, hsPDA, EOS, anemia requiring blood transfusion